Arcus Biosciences, Inc. (RCUS) — Stock Score Summary

Arcus Biosciences, Inc. (RCUS) has a MoatMap StockRank of 24/100 based on Quality (23/100), Value (34/100), and Momentum (53/100) factor scores. The current signal is SELL. Arcus Biosciences is a clinical-stage biotech company. It lacks the commercial-stage cash flows, high ROIC, and pricing power of a quality compounder, making it a poor fit for our investment philosophy.

Arcus Biosciences, Inc. is a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies, targeting critical pathways in immuno-oncology. It specializes in developing small molecule and antibody therapeutics, often pursuing combination strategies to enhance treatment efficacy. Operating in the high-growth immuno-oncology space, Arcus frequently collaborates with larger pharmaceutical companies.

Key Financial Metrics

Price$23.64
Market Cap$3.1B
P/E (Forward)-7.34
Price/Book5.91
Return on Equity-70.0%
Return on Invested Capital-38.0%
Debt/Equity21.57
Gross Margin-121.6%
Operating Margin-788.2%
Revenue Growth-39.3%
Free Cash Flow$-156M

Arcus Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Arcus Biosciences, Inc.’s (RCUS) StockRank?
MoatMap’s StockRank for Arcus Biosciences, Inc. (RCUS) is 24/100, with a Sell signal. It is a composite of Quality (23), Value (34), and Momentum (53) factor ranks across MoatMap’s 19,000+ stock universe.
Does Arcus Biosciences, Inc. have an economic moat?
Arcus Biosciences, Inc. (RCUS) has a Quality factor score of 23/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Arcus Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Arcus Biosciences, Inc. (RCUS) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Arcus Biosciences, Inc. in?
Arcus Biosciences, Inc. (RCUS) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksRCUS deep dive reportAI ChampionsHow we score stocksSense-check another stock